If you’re confused about the growing landscape of weight loss drugs, here is a concise breakdown of their mechanisms, ...

One of these is retatrutide, a drug that's being described as the next big thing in weight loss. Some say it may be even more ...

Here’s how retatrutide works and how it differs from existing weight management medications.

Eli Lilly said its next-generation obesity drug delivered what appears to be the highest weight loss seen so far in a late-stage trial and reduced knee arthritis pain, clearing the first of several ...

Too much of a good thing? Participants taking the highest dose of Eli Lilly’s new GLP-1 drug lost an average of 28.7% of their body weight in a late-stage trial, putting it on track to be a ...

An Eli Lilly drug candidate designed to hit three metabolic targets led patients to lose an average of 28.7% of their body weight in a late-stage clinical trial, setting a new high mark in the ...

A new class of weight-loss drug just took a major step toward approval for use. In a phase 3 clinical trial, the medication ...

You’ve heard of the popular glucagon-like peptide-1 (GLP-1) receptor agonist drug semaglutide (Ozempic, Wegovy) and GLP-1/GIP drug tirzepatide (Mounjaro, Zepbound). Now there’s a new kid on the weight ...

Eli Lilly said its next-generation obesity drug retatutride cleared its first late-stage trial on Type 2 diabetes patients, helping them manage their blood sugar levels and lose weight. The drug ...

The long history of underground drug use abounds with secret societies—colorful cliques of like-minded individuals surreptitiously experimenting with newfangled compounds in an effort to understand ...